CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-26 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −2,192 | $24.35 | $53K | 330,543 |
| 2022-02-26 | Spurr Robert U.S. President-Pharma Business | Shares withheld for taxes | −1,628 | $24.35 | $40K | 68,640 |
| 2022-02-26 | Munsch Frederick SVP, Controller and CAO | Shares withheld for taxes | −306 | $24.35 | $7K | 24,124 |
| 2022-02-26 | Eldessouky Sam EVP & Chief Financial Officer | Shares withheld for taxes | −814 | $24.35 | $20K | 121,615 |
| 2022-02-15 | Spurr Robert U.S. President-Pharma Business | Sale | −3,251 | $25.02 | $81K | 60,299 |
| 2022-02-14 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award · Restricted Share Units | +24,292 | 0 | ||
| 2022-01-18 | Spurr Robert U.S. President-Pharma Business | Sale | −3,251 | $26.63 | $87K | 63,550 |
| 2021-12-31 | DE SCHUTTER RICHARD U Director | Grant or award | +1,245 | $27.61 | $34K | 319,588 |
| 2021-12-31 | WECHSLER AMY B Director | Grant or award | +249 | $27.61 | $7K | 99,054 |
| 2021-12-31 | ROBERTSON RUSSEL C Director | Grant or award | +1,380 | $27.61 | $38K | 126,585 |
| 2021-12-31 | Paulson John Director | Grant or award | +1,109 | $27.61 | $31K | 85,289 |
| 2021-12-31 | Miller Steven D Director | Grant or award | +1,109 | $27.61 | $31K | 61,889 |
| 2021-12-31 | ICAHN BRETT Director | Grant or award | +1,109 | $27.61 | $31K | 11,767 |
| 2021-12-15 | APPIO THOMAS CEO, Pharma Business | Shares withheld for taxes | −3,461 | $24.49 | $85K | 317,225 |
| 2021-11-30 | Miller Steven D Director | Purchase | +50,000 | $24.24 | $1.2M | 60,780 |
| 2021-11-30 | Miller Steven D Director | Purchase | +10,000 | $24.17 | $242K | 10,000 |
| 2021-11-03 | Munsch Frederick SVP, Controller and CAO | Grant or award | +1,246 | 22,418 | ||
| 2021-10-01 | Spurr Robert U.S. President-Pharma Business | Shares withheld for taxes | −283 | $28.60 | $8K | 66,801 |
| 2021-09-30 | WECHSLER AMY B Director | Grant or award | +246 | $27.85 | $7K | 98,805 |
| 2021-09-30 | ROBERTSON RUSSEL C Director | Grant or award | +1,368 | $27.85 | $38K | 125,205 |
Page 18 of 23 · 453 trades